
Propel(X)
Description
Propel(X) is a pioneering online investment platform based in San Francisco, dedicated to funding early-stage companies rooted in scientific discovery and deep technology. It plays a crucial role in connecting accredited investors with groundbreaking startups across diverse sectors, including biotech, advanced materials, artificial intelligence, robotics, space, and clean energy. The platform's mission is to democratize access to venture capital for these capital-intensive, high-potential deep tech ventures.
Propel(X) operates as an angel investing platform, distinguishing itself from traditional venture capital funds. This unique model allows individual accredited investors to participate in funding rounds that might otherwise be inaccessible, leveraging collective capital to provide crucial early-stage funding for startups. The platform's curated deal flow and rigorous due diligence process ensure that investors are presented with thoroughly vetted opportunities, enhancing the quality of potential investments.
Since its inception, Propel(X) has demonstrated significant impact on the deep tech ecosystem. The platform has successfully helped over 100 deep tech startups raise more than $100 million in aggregate funding, showcasing its substantial contribution to nurturing innovation in complex scientific and engineering fields. This aggregated funding comes from a broad base of individual investors.
For individual investors, Propel(X) makes deep tech investing more accessible by allowing participation with relatively modest amounts. Individual investments on the platform typically start from as little as $5,000, enabling a wider range of accredited angels to support cutting-edge scientific and technological advancements.
Investor Profile
Propel(X) has backed more than 66 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 3% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, Canada, Singapore.
- Strong thematic focus on Health Care, Software, Biotechnology.
- Typical check size: $5K – $100K.
Stage Focus
- Seed (56%)
- Series A (14%)
- Series B (12%)
- Series Unknown (8%)
- Convertible Note (3%)
- Private Equity (2%)
- Series E (2%)
- Undisclosed (2%)
- Pre Seed (2%)
- Corporate Round (2%)
Country Focus
- United States (92%)
- Canada (6%)
- Singapore (2%)
Industry Focus
- Health Care
- Software
- Biotechnology
- Manufacturing
- Medical Device
- Artificial Intelligence (Ai)
- Medical
- Sensor
- Information Technology
- Machine Learning
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.